BVCF Leads $7.5M Series A for RiboQuark Pharmaceutical Technology
January 9, 2014 — 09:20 CST
This Data Is Locked!
This area is available only to Subscribers.
Kunshan, Jiangsu Province-based RiboQuark Pharmaceutical Technology has raised around RMB45 million ($7.5 million) in series A financing, according to media reports. Shanghai-based venture capital and... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
